Terms: = Prostate cancer AND uPA AND Diagnosis
5 results:
1. Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of upa/upaR and MMPs.
Qi M; Liu Z; Shen C; Wang L; Zeng J; Wang C; Li C; Fu W; Sun Y; Han B
Tumour Biol; 2015 May; 36(5):3565-72. PubMed ID: 25544710
[TBL] [Abstract] [Full Text] [Related]
2. Tumor markers in prostate cancer I: blood-based markers.
Shariat SF; Semjonow A; Lilja H; Savage C; Vickers AJ; Bjartell A
Acta Oncol; 2011 Jun; 50 Suppl 1(Suppl 1):61-75. PubMed ID: 21604943
[TBL] [Abstract] [Full Text] [Related]
3. Endo180 expression with cofunctional partners MT1-MMP and upaR-upa is correlated with prostate cancer progression.
Kogianni G; Walker MM; Waxman J; Sturge J
Eur J Cancer; 2009 Mar; 45(4):685-93. PubMed ID: 19112015
[TBL] [Abstract] [Full Text] [Related]
4. prostate-specific antigen modulates the expression of genes involved in prostate tumor growth.
Bindukumar B; Schwartz SA; Nair MP; Aalinkeel R; Kawinski E; Chadha KC
Neoplasia; 2005 Mar; 7(3):241-52. PubMed ID: 15799824
[TBL] [Abstract] [Full Text] [Related]
5. Differential expression of upa in an aggressive (DU 145) and a nonaggressive (1013L) human prostate cancer xenograft.
Billström A; Lecander I; Dagnaes-Hansen F; Dahllöf B; Stenram U; Hartley-Asp B
Prostate; 1995 Feb; 26(2):94-104. PubMed ID: 7531848
[TBL] [Abstract] [Full Text] [Related]
